XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash Flows From Operating Activities    
Net loss $ (1,793,699) $ (4,296,042)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 602,195 645,943
Bad debt (recovery) expense 69,641 200,000
Loss on common stock issued in settlement 152,629 0
Gain on extinguishment of debt (579,977) 0
Equity based compensation expense - stock 255,600 762,509
Equity based compensation expense - option 72,214 0
Loss on fair value of marketable securities 141,827 0
Gain on assets sale (250,000) 0
Gain on settlement of debt 0 (178,749)
Change in fair value of warrant liability (67,620) 0
Amortization of debt discount and debt costs 177,072 726,708
Factoring discount fee and interest 0 20,236
Changes in assets and liabilities:    
Decrease in accounts receivable 434,384 591,126
Decrease (increase) in prepaid expenses and other current assets (19,030) (10,262)
Increase (decrease) in accounts payable and accrued liabilities (246,599) (133,506)
(Decrease) increase in deferred revenue (33,739) (40,628)
Net cash (used) in operating activities (1,224,384) (1,712,665)
Cash Flows From Investing Activities:    
Proceeds from sale of assets 250,000 0
Net cash from investing activities 250,000 0
Cash Flows From Financing Activities:    
Proceeds from ERC advances 0 450,000
Repayment of ERC advances 0 (80,528)
Proceeds from sale of common stock in offering 481,000 0
Payments of promissory notes (592,057) 0
Repayments of notes (258,000) (173,027)
Proceeds from factoring agreement 0 871,821
Repayments of factoring agreement 0 (175,127)
Gross proceeds from exercise of warrants 592,057 315,178
Net cash provided by financing activities 223,000 1,208,317
Net decrease in cash (751,384) (504,348)
Cash, beginning of period 1,008,408 946,804
Cash, end of period 257,024 442,456
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 104,293 176,769
Cash paid during the period for income taxes 0 0
Supplemental schedule of non-cash investing and financing activities:    
Accounts receivable owed under factoring agreement collected directly by factor 0 1,000,020
Issuance of common stock upon purchase of intangible assets 647,055 0
Warrants issued in connection with purchase of intangible assets 480,358 0
Issuance of common stock upon conversion of note payable 273,673 0
Issuance of common stock from conversion of Preferred stock, Series E 9 0
Issuance of common stock upon exercise of warrants and conversion of debt 1,115,437 0
Deemed dividends 0 503,643
Offering costs as a result of modification of warrants to induce exercise $ 0 $ 10,400